Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ACB stock hub

Aurora Cannabis Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ACBis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
200.4M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
ACB
In the news

Latest news · ACB

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-15.5
P25 -105.6P50 -46.5P75 -3.1
ROIC-10.1
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ACB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
209
Groups with data
11
Currency
CAD
Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001683541
Company name
Aurora Cannabis Inc.
Country
Canada
Country code
US
Cusip
05156X884
Employees
1,073
Employees Change
-57%
Employees Change Percent
-5.04
Enterprise value
$218M
Exchange
NASDAQ
Financial currency
CAD
First seen
2026-05-09
Industry
Drug Manufacturers - Specialty & Generic
Isin
CA05156X8504
Last refreshed
2026-05-10
Market cap
$200.4M
Market cap category
Micro-Cap
Price
$3.41
Price currency
USD
Rev Per Employee
253,612.71x
Sector
Healthcare
Sic
2833
Symbol
ACB
Website
https://www.auroramj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-30.57%
EV Sales Forward
0.65x
EV/Sales
0.8x
FCF yield
-11.42%
P/B ratio
0.48x
P/S ratio
0.74x
PS Forward
0.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-15.34%
EBITDA Margin
-8.77%
Gross margin
36.03%
Gross Profit
$98M
Gross Profit Growth
-34.86%
Gross Profit Growth Q
-37.79%
Net Income
$-61.3M
Net Income Growth Q
-93.63%
Net Income Growth Years
3%
Pretax Margin
-21.84%
Profit Margin
-22.51%
Profit Per Employee
$-57,090
Profitable Years
1
ROA
-4.36
ROCE
-9.09
ROE
-15.51
ROIC
-10.11
Roic5y
-14.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
-22.79%
Cagr1y
-25.72%
Cagr3y
-19.59%
Cagr5y
-47.92%
EPS Growth Q
-94.69
EPS Growth Years
3
FCF Growth Q
-54.06%
OCF Growth Q
-41.06%
Revenue Growth
16.54x
Revenue Growth Q
6.8x
Revenue Growth Quarters
11x
Revenue Growth Years
2x
Revenue Growth3 Y
20.81x
Revenue Growth5 Y
6.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.45
Assets
$565.4M
Cash
$79.1M
Current Assets
$326.1M
Current Liabilities
$106.8M
Debt
$73.7M
Debt Equity
$0.18
Equity
$414.1M
Interest Coverage
-6.64
Liabilities
$151.3M
Long Term Assets
$239.3M
Long Term Liabilities
$44.6M
Net Cash
$5.4M
Net Cash By Market Cap
$2.71
Net Cash Growth
-3.56%
Net Debt Equity
$-0.01
Tangible Book Value
$346.5M
Tangible Book Value Per Share
$6.11
WACC
10.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.06
Inventory Turnover
0.99
Net Working Capital
$189.1M
Quick ratio
1.05
Working Capital
$218.7M
Working Capital Turnover
$0.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-2.97%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-92.47%
1Y total return
-25.71%
200-day SMA
4.38
3Y total return
-48.02%
50-day SMA
3.47
50-day SMA vs 200-day SMA
50under200
5Y total return
-96.17%
All Time High
1,503
All Time High Change
-99.77%
All Time High Date
2018-10-16
All Time Low
0.01
All Time Low Change
28,316.67%
All Time Low Date
2017-05-31
ATR
0.17
Beta
1.32
Ch YTD
-19.19
High
3.46
High52
6.67
High52 Date
2025-10-09
High52ch
-48.84%
Low
3.38
Low52
3.07
Low52 Date
2026-03-30
Low52ch
11.08%
Ma50ch
-1.62%
Premarket Change Percent
0.58
Premarket Price
$3.45
Premarket Volume
12,237
Price vs 200-day SMA
-22.18%
RSI
47.63
RSI Monthly
36.01
RSI Weekly
40.83
Sharpe ratio
-0.13x
Sortino ratio
-0.11
Total Return
-2.97%
Tr YTD
-19.19
Tr1m
1.19%
Tr1w
-2.01%
Tr3m
-2.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Earnings EPS Estimate
$-0.07
Earnings Revenue Estimate
55,290,000x
Earnings Revenue Estimate Growth
-12.34x
Operating Income
$-41.7M
Operating Income Growth Q
-93.29
Operating margin
-15.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
58,838,663%
Float Percent
103.75%
Net Borrowing
-1,389,122.6
Shares Insiders
0.49%
Shares Institutions
11.5%
Shares Out
56,709,424
Shares Qo Q
1.54%
Shares Yo Y
2.97%
Short Float
11.37%
Short Ratio
11.03
Short Shares
11.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
$-32.2M
Average Volume
1,593,408.4x
Bv Per Share
6.9
CAPEX
$-15.8M
Ch10y
-92.47
Ch1m
1.19
Ch1w
-2.01
Ch1y
-25.71
Ch3m
-2.01
Ch3y
-48.02
Ch5y
-96.17
Ch6m
-25.05
Change
-0.58%
Change From Open
-0.58
Close
3.43
Days Gap
0
Depreciation Amortization
17,915,218.9
Dollar Volume
2,051,319.6
Earnings Date
2026-06-17
Earnings Time
bmo
EBIT
$-41.7M
EBITDA
$-23.9M
EPS
$-1.09
F Score
2
FCF
$-22.9M
FCF EV Yield
-10.5x
FCF Per Share
$-0.4
Financing CF
-490,840
Fiscal Year End
March
Founded
2,013
Goodwill
18,754,983.4
Income Tax
$7.3M
Investing CF
-51,902,824
Is Primary Listing
0
Is Spac
No
Last Earnings Date
2026-02-04
Last Report Date
2025-12-31
Last Split Date
2024-02-20
Last Split Type
Reverse
Ma150
4.17
Ma150ch
-18.28%
Ma20
3.5
Ma20ch
-2.68%
Net CF
-55,620,223
Next Earnings Date
2026-06-17
Open
3.43
Optionable
Yes
Position In Range
37.5
Post Close
3.41
Postmarket Change Percent
-0.79
Postmarket Price
$3.38
Ppne
189,539,519.4
Pre Close
3.43
Price Date
2026-05-08
Ptbv Ratio
0.58
Relative Volume
0.38x
Revenue
272,126,437x
SBC By Revenue
3.42x
Share Based Comp
9,315,013
Tax By Revenue
2.69x
Tr6m
-25.05%
Volume
601,560
Z Score
-9.77
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ACB pay a dividend?

Capital-return profile for this ticker.

Performance

ACB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-25.7%
S&P 500 1Y: n/a
3Y total return
-48.0%
S&P 500 3Y: n/a
5Y total return
-96.2%
S&P 500 5Y: n/a
10Y total return
-92.5%
S&P 500 10Y: n/a
Ownership

Who owns ACB?

Insider, institutional, and short-interest positioning.

Institutional ownership
+11.5%
Float: +103.8% of shares outstanding
Insider ownership
+0.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+11.4%
11.0 days to cover
Y/Y dilution
+3.0%
Negative means the company is buying back shares.
Technical

ACB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.6
Neutral momentum band
Price vs 200-day MA
-22.2%
50/200-day relationship not available
Beta (5Y)
1.32
More volatile than the market
Sharpe ratio
-0.13
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ACB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ACB stock rating?

Aurora Cannabis Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ACB analysis?

The full report lives at /stocks/ACB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ACB?

The latest report frames ACB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ACB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.